Fund HoldingsOctagon Capital Advisors LP

Total Portfolio Value
$1.09B
Total Bought
$231.41M
Total Sold
$154.62M
Net Transaction
+$76.79M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
DEFINIUM THERAPEUTICS INC(DFTX)2,440,0002,950,000+510,00046,116138,76812.74%+92,652
ABIVAX SA(ABVX)677,000993,000+316,00075,384132,32712.15%+56,943
TAYSHA GENE THERAPIES INC(TSHA)8,859,9119,693,244+833,33339,60466,0116.06%+26,407
ARRIVENT BIOPHARMA INC(AVBP)1,971,0541,971,054045,47268,4746.28%+23,002
SUMMIT THERAPEUTICS INC(SMMT)01,250,000+1,250,000018,2131.67%+18,213
ALUMIS INC2,830,7002,830,700062,36079,6567.31%+17,296
DIANTHUS THERAPEUTICS INC(DNTH)1,946,6671,841,667-105,000163,364179,52616.48%+16,161
AKTIS ONCOLOGY INC(AKTS)960,847960,847017,19030,9682.84%+13,779
BIOAGE LABS INC(BIOA)1,748,0001,748,000030,57342,8433.93%+12,271
PHARVARIS N V
COM
165,000456,721+291,7214,66115,7931.45%+11,132
ADLAI NORTYE LTD(ANL)0934,716+934,716010,7490.99%+10,749
FAETH THERAPEUTICS INC(FTH)0361,010+361,01009,0250.83%+9,025
MIRUM PHARMACEUTICALS INC(MIRM)338,900338,900031,30839,6753.64%+8,367
GYRE THERAPEUTICS INC(GYRE)0954,416+954,41606,2900.58%+6,290
PALISADE BIO INC(PALI)10,276,31710,276,317017,98421,4781.97%+3,494
DISC MEDICINE INC(IRON)270,000270,000017,26419,7481.81%+2,484
XENON PHARMACEUTICALS INC(XENE)490,000490,000028,49429,5762.71%+1,083
COGENT BIOSCIENCES INC(COGT)2,350,0002,350,000090,45290,9458.35%+494
KYMERA THERAPEUTICS INC(KYMR)425,000310,000-115,00035,39835,5483.26%+149
GOSSAMER BIO INC(GOSS)7,750,0007,750,00002,5461,2760.12%-1,270
PRECISION BIOSCIENCES INC(DTIL)2,236,7321,350,000-886,73212,30210,6110.97%-1,691
UNICYCIVE THERAPEUTICS INC(UNCY)1,000,0001,000,00006,5804,6900.43%-1,890
DBV TECHNOLOGIES S A(DBVT)574,200574,200011,9959,4170.86%-2,578
EVOMMUNE INC(EVMN)143,4720-143,4723,2980-3,298
PERSPECTIVE THERAPEUTICS INC(CATX)791,5550-791,5553,3010-3,301
LEXEO THERAPEUTICS INC(LXEO)1,100,0000-1,100,0006,3140-6,314
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)719,0000-719,0006,4350-6,435
OCULAR THERAPEUTIX INC(OCUL)3,166,6002,075,000-1,091,60026,82120,3771.87%-6,445
TREVI THERAPEUTICS INC(TRVI)1,485,000315,000-1,170,00017,7165,8750.54%-11,841
CONTEXT THERAPEUTICS INC(CNTX)5,250,0003,050,000-2,200,00013,7551,6890.16%-12,066
TERNS PHARMACEUTICALS INC530,0000-530,00027,9420-27,942
KALVISTA PHARMACEUTICALS INC1,450,0000-1,450,00029,1890-29,188
CENTESSA PHARMACEUTICALS PLC750,0000-750,00029,7900-29,790
Page 1 of 1
Octagon Capital Advisors LP — 13F Holdings — Q2 2026 | TickerTrail